The activation of the PI3K/AKT/mTOR signaling pathway plays a role in the invasiveness of HCC, and it is frequently detected in immunohistochemical analyses of patients’ HCC tissues [61,62,63,64,65,66,67]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.